However, given the low frequency of Rac1 missense mutants (0.01–0.02% for G15, C18 [118]) such rare mutations would be undetectable in the sample size and should not be taken as lack of evidence for the importance of Rac1 in ovarian cancer. The gene discussed is RAC1; the disease is ovarian cancer.